Genentech and Samsung Bioepis settle patent dispute over cancer biosimilar
05-07-2019
Genentech enters agreement to develop autoimmune therapies
21-05-2019
jejim / Shutterstock.com
A Japanese court has dismissed a patent infringement lawsuit brought by Roche subsidiary Genentech against Sandoz, a division of Novartis.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Genentech, Sandoz, Chugai Pharmaceutical, Tokyo District Court, Rituxan, biosimilar
